Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prof Lars Fugger
Prof Lars Fugger

Congratulations for their recent success go to:

Prof Lars Fugger - Wellcome Trust Senior Investigator Award

Prof Fugger received the award for his work on Multiple Sclerosis. His group is seeking to understand the molecular basis for interactions between genetic and environmental risk factors through a multidisciplinary approach, which combines analysis of both clinical samples and humanised transgenic in vivo models. Their goal is to develop new therapeutic avenues for MS by gaining insight into disease pathways, which can be manipulated through both novel drugs and drug repositioning. 

Prof Fugger trained at the University of Copenhagen and at Stanford University. He became Professor of Clinical Immunology at the University of Oxford in 2004 and Professor of Neuroimmunology in 2007 in the NDCN.

Prof Kia Nobre – MRC Partnership Grant

Prof Kia Nobre and colleagues at the Oxford Centre for Human Brain Activity were part of a collaboration of MEG researchers across the UK to receive a £1.3m Partnership Grant from the MRC to enhance MEG training, collaboration, and data sharing.

Dr Martin Turner – MRC Senior Clinician Scientist Fellowship

Dr Turner is a Consultant Neurologist and Clinician Scientist in NDCN. His research focus is the neurodegenerative disorder Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS) in its commonest form.

Dr Gwenaelle Douaud – MRC Career Development Award

Dr Douaud is part of the FMRIB Analysis Group. She focuses on translational research from imaging methods to applied human neuroscience, such as brain maturation and ageing, and with a particular emphasis on neurodegenerative disorders (Alzheimer's disease, movement disorders and motor neuron disease).

Dr Chris Butler - MRC Scientist-Clinician Fellowship

Dr Butler is investigating the functional and neural basis of accelerated forgetting in patients with transient epileptic amnesia.

 

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.